Executive summary
- Consensus reports indicate that diabetes and periodontitis exhibit a bidirectional relationship, as elevated blood glucose levels correlate with more severe gum disease, while gum inflammation is linked to poorer glycaemic control (Ref 2, Ref 3).
- In mice with diabetes, inhibiting the advanced glycation end product receptor decreased both periodontal bone loss and gingival inflammatory mediators; however, the situation in humans might be different (Ref 5).
- Overweight US adults without diabetes who had high physiological insulin resistance were found to have a greater likelihood of severe periodontal disease, according to cross-sectional data that is unable to establish the order of events (Ref 7).
- In a big US group, initial poorer gum health showed an association with a greater likelihood of later diabetes, yet this alone doesn't prove causation (Ref 9).
- The latest Cochrane review suggested that moderate-certainty evidence supports the idea that professional periodontal treatment reduces HbA1c levels by approximately 0.4 percentage points within a three-to-four-month period, although most trials featured in the analysis had a high or unclear risk of bias (Ref 12).
- The biggest individual study of non-surgical periodontal therapy in individuals with type 2 diabetes, conducted in the United States, was halted prematurely due to lack of effectiveness and showed no enhancement in glycaemic control after six months (Ref 13).
- Among dental patients who have risk factors for diabetes, two oral observations detected roughly three quarters of individuals with pre-diabetes or diabetes, rising to around 90 per cent when used alongside a finger-prick HbA1c test (Ref 15).
- A randomised trial involving a small group demonstrated that modifying one's diet led to a reduction in gingival bleeding despite no alteration in plaque levels among individuals with gingivitis, albeit the diet in question was characterised by a minimal intake of animal protein and an abundance of plant-based foods (Ref 17).
I earned my dental degree before pursuing additional postgraduate qualifications in anti-ageing medicine, dermatology, metabolic medicine, and sports nutrition. I view dentistry and metabolic medicine as addressing one issue but from opposite angles, given my dual training. Periodontitis and diabetes are linked in a bidirectional way, according to current consensus literature, with inflammation suggested as the connecting factor.
I need to disclose my commercial ties and dietary perspective right away. I operate a private practice where I provide consultations for a fee. My stance favours a strictly carnivorous diet, with animal products being the sole source of food I consume and endorse, while I assert that carbohydrates hold no essential status as a nutrient. The way I interpret the data is influenced by my stance. None of the referenced trials or consensus documents explicitly evaluated dietary impact. Additionally, I presented standard evidence that runs counter to my argument.
The consensus on a two-way relationship
In 1993, Löe suggested recognising severe periodontitis as the sixth complication associated with diabetes (Ref 1). Löe suggested this as an idea rather than an official categorisation. In 2017 and 2018, the International Diabetes Federation and the European Federation of Periodontology released a joint consensus report characterising diabetes and periodontitis as chronic non-communicable diseases with independent links to mortality and a bidirectional relationship (Ref 2). An earlier consensus review suggested that severe periodontitis impacts 10 to 15 per cent of adults, while people with diabetes face about a threefold higher risk of developing it (Ref 3).
According to the same review, higher blood sugar levels are associated with more severe periodontitis. Severe periodontitis in individuals with diabetes is associated with increased rates of kidney complications and cardiorenal death, as per observational data, though these findings may be influenced by factors such as smoking, diabetes duration, and socioeconomic status (Ref 3). A previous review also emphasises that bacterial plaque is the main trigger for periodontal disease, while diabetes modifies the body's reaction to it (Ref 4).
How high blood glucose may worsen gum disease
Reviewers indicate that while the mechanisms are not fully understood, they involve immune functioning, neutrophil activity, and cytokine biology (Ref 3). The older review highlights that diabetes has been linked to impaired neutrophil chemotaxis, where white blood cells fail to move towards infections, along with faulty collagen metabolism and slower wound healing, with some evidence coming from animal studies (Ref 4). The review observes that individuals with diabetes might exhibit plaque scores comparable to or even lower than those without diabetes, yet their gingival inflammation scores are frequently elevated. Published in 1996, this review is old and relies partly on rat studies.
Administering soluble RAGE to inhibit the receptor for advanced glycation end products (RAGE) in diabetic mice infected with the human periodontal pathogen Porphyromonas gingivalis reduced alveolar bone loss in proportion to the dosage (Ref 5). The concentrations of proinflammatory cytokines, specifically tumour necrosis factor-alpha and interleukin-6, within gingival tissue decreased, along with the levels of matrix metalloproteinases and gingival advanced glycation end products. This study involved just a single experiment on mice, and RAGE could be just one of several factors influencing the outcomes, and results in humans might vary.
How gum inflammation may worsen glucose control
The reverse relationship could also exist. Periodontitis involves elevated levels of interleukin-6, an inflammatory mediator (Ref 2), and individuals who later develop type 2 diabetes have also been found to have increased levels of this cytokine. Among a cohort of 27,628 women in a prospective nested case-control study, baseline levels of C-reactive protein and interleukin-6 were significantly elevated in the 188 individuals who developed diabetes within four years compared to 362 matched controls. When comparing the top and bottom quartiles, the likelihood of developing diabetes in the future was 7.5 times higher for interleukin-6 and 15.7 times higher for C-reactive protein; however, after accounting for body mass index, family history, smoking, and other variables, the relative risk dropped to 4.2 for C-reactive protein, and the interleukin-6 link was no longer statistically meaningful (Ref 6). The research didn't look at gums whatsoever; it only identified associations, and it remains unclear if these markers have a causative role.
In the NHANES III survey, a cross-sectional study involving 12,367 non-diabetic US adults, body mass index showed a positive association with the extent of periodontal attachment loss. In overweight people with a body mass index of 27 or higher, the likelihood of severe periodontal disease was 1.48 times greater in those with elevated physiological insulin resistance (this condition, which the authors refer to as insulin resistance, describes cells that block glucose entry despite insulin signalling) than in those with low insulin resistance (Ref 7). Survey data was used to estimate insulin resistance instead of direct measurement. This cross-sectional design precludes establishing temporal sequence and leaves residual confounding as a potential issue.
Does periodontitis come before diabetes?
A longitudinal study conducted early on in a Native American population found that severe periodontitis at the initial assessment was associated with a higher risk of poor glycaemic control during subsequent follow-up among adults diagnosed with type 2 diabetes (Ref 8). The uncertainty of generalisation arises from the limited sample size (80 and 88 individuals for the two dental assessments) taken from a single population.
Among 9,296 non-diabetic individuals in a large US study group, those assessed from 1971 to 1976 and followed up between 1982 and 1992 had an increased likelihood of developing diabetes if they initially had more severe periodontal disease. The adjusted odds ratios for developing diabetes in the three groups with the most severe periodontal disease were 2.26 (95 per cent confidence interval 1.56 to 3.27), 1.71 (1.0 to 2.69) and 1.50 (0.99 to 2.27) when compared to those with healthy periodontium (Ref 9). The observational nature of this study means that residual confounding could be present, and it's possible that undiagnosed diabetes at baseline led to gum disease instead of the other way around. Cases of newly diagnosed diabetes were detected through death certificates, self-reported treatment, or hospital discharge codes, potentially overlooking milder instances. The periodontal index applied in the dental exam was older, and the lower limits of confidence for two categories either hit 1 or dip slightly beneath it, without the odds showing a consistent increase with worsening severity.
Genetic evidence provides some backing for this hypothesis, as periodontitis predicted by genetics was linked to an elevated type 2 diabetes risk, showing an odds ratio of 1.469 (Ref 10). The study additionally found a minimal link between periodontitis and physiological insulin resistance, showing an odds ratio of 1.034. The results presented come from a single study, and they are based on Mendelian randomisation, whose assumptions can't be verified from the abstract alone, and a genetic marker for periodontitis might reflect immune characteristics common to both diabetes and gum disease, rather than gum disease itself.
Treating the gums and HbA1c: the trials
The 2015 Cochrane systematic review concluded that the evidence was of low quality and identified no distinct impact after six months (Ref 11). The 2022 update, which includes additional trials and participants (35 studies with 3,249 people), assesses the evidence as having moderate certainty. Participants assigned to periodontal treatment achieved an absolute decrease in HbA1c of 0.43 percentage points (95 per cent confidence interval 0.28 to 0.59) after three to four months versus no treatment or standard care, with a 0.30 point reduction observed at six months (Ref 12). This reduction was considered by the authors to be clinically significant. Among the 35 trials included, just two had a low risk of bias, whereas 14 were classified as high risk and 19 as unclear. The studies mostly took place in secondary care settings and nearly all focused on type 2 diabetes, with varying comparators and most not assessing adverse effects.
The Diabetes and Periodontal Therapy Trial, the biggest individual study conducted in this field, involved 514 adults in the United States who have type 2 diabetes and were either assigned to receive scaling and root planing (including a chlorhexidine rinse and follow-up therapy at three and six months) or no intervention. The trial was halted prematurely due to futility, as it revealed no significant change in HbA1c levels at six months, showing a between-group difference of 0.05 percentage points (95 per cent confidence interval from 0.23 lower to 0.12 higher) (Ref 13). The treated group showed better gum measures, although participants were already on consistent diabetes medication with baseline HbA1c ranging from 7 to under 9 per cent, and the periodontal benefits were slight, roughly a quarter of a millimetre in probing depth, potentially leaving some inflammation.
A 12-month study conducted in the UK involved 264 adults with type 2 diabetes who were randomly assigned to either receive intensive periodontal treatment or standard supragingival scaling and polishing as a control. The intensive group showed a 0.6 percentage point lower HbA1c after accounting for baseline variables; without adjustment, the difference was 0.5 points, with values of 7.8 per cent compared to 8.3 per cent (Ref 14). The UK study employed a more intensive treatment approach, including supportive therapy every three months, and started with a higher baseline HbA1c (8.1 per cent) compared to the US trial. The study took place at a single centre, with dental staff unmasked during treatment, and adverse events occurred more often in the intensive group (23 versus 18 per cent), despite serious events being the same in both groups. The two trials vary in population, duration and design, preventing direct contradiction, but the single-trial evidence presents a mixed picture, despite the pooled analysis showing moderate positivity. The long-term sustainability of the effect remains unclear (Ref 2, Ref 11).
Can a dentist spot undiagnosed hyperglycaemia?
A cross-sectional validation study carried out in New York revealed that a straightforward criterion (either 26 per cent or more of teeth exhibiting deep pockets, or four or more missing teeth) accurately pinpointed 75 per cent of pre-diabetes or diabetes instances among the entire group of 1,097 individuals. Including a point-of-care HbA1c test result of 5.7 per cent or higher increased accurate detection to 90 per cent (Ref 15). The result came from a specific group of dental patients who already had diabetes risk factors, meaning it doesn’t reflect a general population screening estimate, and the false-positive rate isn’t mentioned in the abstract.
A meta-analysis evaluating dental-setting screening found that 11.23 per cent had undiagnosed type 2 diabetes and 47.38 per cent had prediabetes (Ref 16). The findings were combined from nine studies involving specific dental patients screened using point-of-care tests, not the entire dental-attending population. Many of those singled out by a single test might be false positives, requiring confirmation through additional laboratory testing.
Diet and what remains unknown
While I hold this idea with caution, my current working theory suggests that carbohydrate intake might promote both gum plaque and gum inflammation. A diet that drastically reduces carbohydrate intake to almost nothing could potentially decrease the amount of fuel in the mouth and lower levels of circulating glucose and insulin, which is a biologically plausible and testable idea. What I have seen in clinical practice aligns with this, but clinical observation alone does not establish causation, and none of the referenced studies demonstrates that carbohydrate restriction addresses periodontitis or reduces HbA1c via the gums. I remain willing to review any future evidence that contradicts this.
The existing trial evidence is limited. A randomised trial involving 30 gingivitis patients had the experimental group follow a diet low in processed carbohydrates and animal proteins, but high in omega-3 fatty acids, vitamin C, vitamin D, antioxidants, plant nitrates and fibres, for four weeks. The experimental group exhibited a notable decrease in gingival bleeding, but there were no variations in plaque levels, blood inflammatory markers, or the subgingival microbiome when compared to the other group (Ref 17). The findings align with diet influencing gum reactions, rather than just plaque levels. The diet used was high in plant foods and low in animal protein, which contradicts my stance. The study altered multiple factors simultaneously, such as body weight. Both groups stopped interdental cleaning, and the study focused on gingivitis instead of periodontitis.
Genetic predisposition to increased consumption of dried and fresh fruits was linked in a distinct Mendelian randomisation study to a lower likelihood of developing acute and chronic gingivitis, as well as bleeding gums. Increased water consumption correlated with decreased instances of chronic gingivitis and bleeding gums. The frequency of alcohol consumption and the consumption of processed meat were identified as risk factors for bleeding gums (Ref 18). The findings depend on genetic proxies for self-reported dietary habits, which involve assumptions that are not entirely verifiable, and the odds ratios for gingivitis were highly imprecise (0.02 for acute gingivitis, with a range from 0.00 to 0.42). The dietary findings do not address carbohydrate limitation or an exclusively animal-based diet, and while I regard correlation-based nutrition studies as weak evidence, they still represent conventional evidence that challenges a strictly meat-based perspective.
What this means in practice
From my perspective, the discrepancy between effective hygiene and persistent gum inflammation, or recurring poor healing, suggests a need to consider metabolic health. Wound healing delays are associated with diabetes (Ref 4, partly from animal work). I’m unable to see you, and nothing here constitutes a diagnosis. If your gums bleed even with proper cleaning or healing is slower than expected, it might be worth talking to your own clinician about an HbA1c test and consulting a dentist for a periodontal assessment, depending on your specific situation. Any adjustment to your medication, for those with diabetes, should be discussed with the clinicians overseeing your treatment.
From my clinical perspective, routine dental care remains important, including the use of an electric toothbrush, interdental cleaning, and consulting a periodontist when necessary. The consensus advises that maintaining oral and periodontal health should be considered a key component in managing diabetes (Ref 3).
Disclosures
As the operator of a private clinic providing paid consultations, I stand to gain if readers find this type of analysis beneficial. My stance favours a carnivore diet, where I consume and advocate exclusively for animal-based foods, leading me to interpret the research through that perspective, such as the diet-related findings discussed earlier. The contents of this article should not be considered personal medical advice or a replacement for recommendations from your healthcare professionals. I provide consultations to assist you in applying this information to your personal situation, but you are free to choose from other skilled clinicians.
References
- Löe H. Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care. 1993;16(1):329-334. PMID: 8422804. https://pubmed.ncbi.nlm.nih.gov/8422804/
- Sanz M, Ceriello A, Buysschaert M, et al. Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology. J Clin Periodontol. 2018;45(2):138-149. PMID: 29280174. https://doi.org/10.1111/jcpe.12808
- Preshaw PM, Alba AL, Herrera D, et al. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2012;55(1):21-31. PMID: 22057194. https://doi.org/10.1007/s00125-011-2342-y
- Grant-Theule DA. Periodontal disease, diabetes, and immune response: a review of current concepts. J West Soc Periodontol Periodontal Abstr. 1996;44(3):69-77. PMID: 9477864. https://pubmed.ncbi.nlm.nih.gov/9477864/
- Lalla E, Lamster IB, Feit M, et al. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest. 2000;105(8):1117-1124. PMID: 10772656. https://doi.org/10.1172/JCI8942
- Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327-334. PMID: 11466099. https://doi.org/10.1001/jama.286.3.327
- Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y. A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol. 2005;76(11 Suppl):2075-2084. PMID: 16277579. https://doi.org/10.1902/jop.2005.76.11-S.2075
- Taylor GW, Burt BA, Becker MP, et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol. 1996;67(10 Suppl):1085-1093. PMID: 8910827. https://doi.org/10.1902/jop.1996.67.10s.1085
- Demmer RT, Jacobs DR, Desvarieux M. Periodontal disease and incident type 2 diabetes: results from the First National Health and Nutrition Examination Survey and its epidemiologic follow-up study. Diabetes Care. 2008;31(7):1373-1379. PMID: 18390797. https://doi.org/10.2337/dc08-0026
- Wei X, Zhang X, Chen R, et al. Impact of periodontitis on type 2 diabetes: a bioinformatic analysis. BMC Oral Health. 2024;24(1):635. PMID: 38811930. https://doi.org/10.1186/s12903-024-04408-1
- Simpson TC, Weldon JC, Worthington HV, et al. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus. Cochrane Database Syst Rev. 2015;(11):CD004714. PMID: 26545069. https://doi.org/10.1002/14651858.CD004714.pub3
- Simpson TC, Clarkson JE, Worthington HV, et al. Treatment of periodontitis for glycaemic control in people with diabetes mellitus. Cochrane Database Syst Rev. 2022;4(4):CD004714. PMID: 35420698. https://doi.org/10.1002/14651858.CD004714.pub4
- Engebretson SP, Hyman LG, Michalowicz BS, et al. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial. JAMA. 2013;310(23):2523-2532. PMID: 24346989. https://doi.org/10.1001/jama.2013.282431
- D'Aiuto F, Gkranias N, Bhowruth D, et al. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial. Lancet Diabetes Endocrinol. 2018;6(12):954-965. PMID: 30472992. https://doi.org/10.1016/S2213-8587(18)30038-X
- Lalla E, Cheng B, Kunzel C, Burkett S, Lamster IB. Dental findings and identification of undiagnosed hyperglycemia. J Dent Res. 2013;92(10):888-892. PMID: 23979781. https://doi.org/10.1177/0022034513502791
- Chinnasamy A, Moodie M. Prevalence of undiagnosed diabetes and prediabetes in the dental setting: a systematic review and meta-analysis. Int J Dent. 2020;2020:2964020. PMID: 32908510. https://doi.org/10.1155/2020/2964020
- Woelber JP, Gärtner M, Breuninger L, et al. The influence of an anti-inflammatory diet on gingivitis. A randomized controlled trial. J Clin Periodontol. 2019;46(4):481-490. PMID: 30941800. https://doi.org/10.1111/jcpe.13094
- Ying XX, Hou Y, Zheng X, et al. Exploring putative causal associations between diet and periodontal disease susceptibility. JDR Clin Transl Res. 2024;10(1):44-53. PMID: 38708597. https://doi.org/10.1177/23800844241247485